You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{d.Title}}
{{psData[masterIndex].Blurb}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{n.Blurb}}
{{s.Title}}
{{l.Title}}
Welcome, {{userName}}
{{'MP_HEADER_LOG_IN' | translate}}
{{countryCode}}
{{'SEARCH_MODAL_TITLE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{c.Title}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{s.Title}}
{{l.Title}}
Page Content
Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions
NHS England chooses Spectra Optia for expansion of sickle cell disease treatment
Honoring World Blood Donor Day 2022
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
Terumo Secures $10.6M from U.S. Government Funding for Freeze-Dried Plasma Project
Gawin is the only female and non-Japanese member in this important role, Read More
Learn more about this next generation, automated technology
Lilian Chebet is alive today because of blood donors.
Watch Now
Collaboration to launch breakthrough cancer immunotherapy treatment in Europe.
Learn more
New manufacturing facility inaugurated in Costa Rica.
Learn more
QUICK LINKS
Get Product Support
Find Technical Documents
Find Certificates of Compliance
Get Training
Start a Career With Us
Distributor News
Modern Slavery Act Statement
LATEST NEWS
Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions
Honoring World Blood Donor Day 2022
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
Terumo Blood and Cell Technologies Receives $10.6M Contract From U.S. Government to Continue Freeze-Dried Plasma Development
Antoinette Gawin is the only female and non-Japanese member in an important new Terumo Corporation GMEO role.
Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development
Queen’s University Belfast and Terumo Blood and Cell Technologies collaborate in Knowledge Transfer Partnership to develop next generation pharmaceutical packaging
U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology
{{'SEARCH_MODAL_TITLE' | translate }}
{{s.Query|stripSpecialChars}}
{{'SEARCH_MODAL_OR' | translate }}
{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_PRODUCT' | translate }}
{{productCode.RefinementName}}
{{'SEARCH_MODAL_CATEGORY' | translate }}
{{categoryCode.RefinementName}}
{{'SEARCH_SMODAL_SEGMENT' | translate }}
{{segmentCode.RefinementName}}
{{'SEARCH_MODAL_SHOW_BROWSE_RESULTS' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }}
{{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}